(19)

(11)

EP 4 132 552 A2

(12)

(88) Date of publication A3: 02.12.2021 (43) Date of publication: 15.02.2023 Bulletin 2023/07 (21) Application number: 21723463.2 (22) Date of filing: 05.04.2021

(51) International Patent Classification (IPC):  A61K 35/76(1974.07) A01N 63/40(2020.01) A61P 31/04(2000.01) C12N 7/00(1980.01) A61L 15/00(1968.09) A61L 29/16(2000.01) C12N 1/00(1980.01) C12Q 1/14(1980.01) (52) Cooperative Patent Classification (CPC): A61K 35/76; C12Q 1/14; A61P 31/04; C12N 7/00; C12Q 1/04; Y02A 50/30; C12N 2795/00032 (86) International application number: PCT/US2021/025794 (87) International publication number: WO 2021/207082 (14.10.2021 Gazette 2021/41)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 06.04.2020 US 202063005878 P 16.06.2020 US 202063039475 P (71) Applicant: Adaptive Phage Therapeutics, Inc. Gaithersburg, MD 20878 (US)	(72) Inventors: BASU, Subhendu Frederick,, Maryland 21704 (US) HOPKINS, Robert Clarksburg, Maryland 20871 (US) MERRIL, Greg Bethesda, Maryland 20814 (US) FACKLER, Joseph Gaithersburg, Maryland 20877 (US) (74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB  Siebertstraße 3 81675 München 81675 München (DE)